M. BEKSAÇ Et Al. , "High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre," 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group , vol.33, Barcelona, Spain, 2004
BEKSAÇ, M. Et Al. 2004. High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre. 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group , (Barcelona, Spain).
BEKSAÇ, M., Soydan, E., Arat, M., Topcuoglu, P., YÜKSEL, M., TOPRAK, S. K., ... Kizil, M.(2004). High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre . 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain
BEKSAÇ, MERAL Et Al. "High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre," 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 2004
BEKSAÇ, MERAL Et Al. "High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre." 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group , Barcelona, Spain, 2004
BEKSAÇ, M. Et Al. (2004) . "High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre." 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group , Barcelona, Spain.
@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre}, congress name={30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group}, city={Barcelona}, country={Spain}, year={2004}}